Please log in to save bookmarks. Only registered users can save their favorite pages.
Journal Properties
Formerly known as
Current Drug Targets: Inflammation and Allergy
Language
English
Number of Articles
437
ISSN
1871-5281
Main Publisher
Bentham Science Publishers
Publisher
Bentham Science Publishers Ltd.
Indian UGC
DOAJ (latest)
Description
This journal focuses on the discovery and development of novel drug targets for the treatment of inflammation and allergic diseases. It provides a multidisciplinary platform for researchers and clinicians to share insights into the molecular mechanisms underlying these conditions.
Core areas of interest include the identification of new therapeutic targets, the development of innovative drug candidates, and the evaluation of their efficacy and safety in preclinical and clinical studies. Indexed in reputable databases, this publication serves as an essential resource for scientists, pharmaceutical companies, and healthcare professionals dedicated to advancing the treatment of inflammatory and allergic disorders.
By facilitating the exchange of knowledge and fostering collaboration, this journal aims to accelerate the development of more effective and targeted therapies for patients suffering from these debilitating conditions. Researchers are invited to submit.